How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, AbbottInvestors Business Daily • 05/28/25
Boston Scientific to not seek US approval for heart device amid regulatory challengesReuters • 05/28/25
Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 05/23/25
Two S&P 500 Giants And Tesla's Main Rival Lead 5 Stocks In Buy AreasInvestors Business Daily • 05/17/25
Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now?Zacks Investment Research • 05/14/25
Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)Seeking Alpha • 05/13/25
MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to KnowZacks Investment Research • 05/05/25
EMEA Growth & Product Launches to Support Boston Scientific StockZacks Investment Research • 04/28/25
MercadoLibre, The Amazon Of Latin America, Leads Five Stocks Near Buy PointsInvestors Business Daily • 04/26/25
Here is Why Growth Investors Should Buy Boston Scientific (BSX) NowZacks Investment Research • 04/25/25
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpointsPRNewsWire • 04/24/25
Boston Scientific (BSX) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/23/25
Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO TransitionBenzinga • 04/23/25
Boston Scientific Stock Jets 8% Higher On Solid Quarterly Beat, Hiked GuidanceInvestors Business Daily • 04/23/25